Sham Mailankody, MBBS
Memorial Sloan Kettering Cancer Center
5
5
2
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Avigan, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
PEGOURIE, MD
University Hospital, Grenoble
Shared therapeutic areas:
Michel ATTAL, MD, PhD
University Hospital, Toulouse
Shared therapeutic areas:
AUGEL MEUNIER, MD
CHU ST PRIEST EN JAREZ
Shared therapeutic areas:
MOREL, MD
Hôpital la Pitié Salpêtrière Paris
Shared therapeutic areas:
BENBRAHIM, MD
CH ORLEANS
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Gustavo Leone
Medical University of South Carolina, Hollings Cancer Center
Shared therapeutic areas:
WETTERWALD, MD
CH DUNKERQUE
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
Short Course Daratumumab in Patients With Multiple Myeloma
Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
All 5 trials loaded